Novel & Dual Payloads: Assessing Linker Conjugation Technologies That Encourage Flexibility in Payloads

Time: 3:50 pm
day: Day One P3

Details:

  • Evaluating the right ratios, the advantages of releasing drugs in specific ratios, and which combination of drugs make sense when considering dual payloads
  • Discussing the parameters of small molecule degraders and how that lends them to make good payloads
  • Advancing cytoxic or immune-stimulating payloads with novel MoAs

Speakers: